plegridyhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /en_us/home/404.html Disallow: /en_us/home/500.html Disallow: /en_us/home/thank-you.html Disallow: /en_us/home/unsubscribe/unsubscribe-confirmation.html Disallow: /en-us/content/commercial Disallow: /*.p.html Disallow: /*.email.html Disallow: /*.display.html | ||
Meta Tags
| Title | Relapsing MS Treatment | PLEGRIDY® (peginterferon beta-1a) | HCP |
| Description | The high-dose, low-frequency Official Healthcare Professional site for PLEGRIDY® (peginterferon beta-1a). Find info for your Relapsing MS patients here. See full Prescribing & Safety |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.55.153.90 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
plegridyhcp.com Valuation
|
US$2,864,206
Last updated: 2022-06-24 06:11:53
plegridyhcp.com has Semrush global rank of 3,695,372. plegridyhcp.com has an estimated worth of US$ 2,864,206, based on its estimated Ads revenue. plegridyhcp.com receives approximately 330,486 unique visitors each day. Its web server is located in United States, with IP address 52.55.153.90. According to SiteAdvisor, plegridyhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,864,206 |
| Daily Ads Revenue | US$2,644 |
| Monthly Ads Revenue | US$79,317 |
| Yearly Ads Revenue | US$951,798 |
| Daily Unique Visitors | 22,033 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| plegridyhcp.com. | A | 299 | IP: 52.55.153.90 |
| plegridyhcp.com. | A | 299 | IP: 18.214.255.239 |
| plegridyhcp.com. | NS | 86400 | NS Record: ns-264.awsdns-33.com. |
| plegridyhcp.com. | NS | 86400 | NS Record: ns-615.awsdns-12.net. |
| plegridyhcp.com. | NS | 86400 | NS Record: ns-1198.awsdns-21.org. |
| plegridyhcp.com. | NS | 86400 | NS Record: ns-2032.awsdns-62.co.uk. |
| plegridyhcp.com. | TXT | 300 | TXT Record: google-site-verification=95b7Dx_vrj6RIbBYSUMt35dhFVWWIPyoxBDdNsOojEA |
HtmlToTextCheckTime:2022-06-24 06:11:53
| Prescribing Information Medication Guide Important Safety Information Patient Site Instructions for Use Important Safety Information Patient Website Prescribing Information Toggle navigation BIOGEN SUPPORT 800.456.2255 Start PLEGRIDY Getting started Dosing Support program Efficacy Safety Well-established safety profile Adverse reactions Managing common side effects Special populations Access and reimbursement E-Sign Start Form Download Start Form BIOGEN SUPPORT BIOGEN SUPPORT 800.456.2255 Prescribing Information Medication Guide Important Safety Information Patient Site Instructions for Use The high-dose, low-frequency interferon for the treatment of relapsing multiple sclerosis (MS) 1,2 Help patients start PLEGRIDY Efficacy 1,2 The ADVANCE clinical trial examined 3 key measures of disease activity Review the data Safety and tolerability 1 Review the well-established safety profile and strategies to address tolerability See safety One injection every 2 weeks 1 Find out if dosing with |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: awselb/2.0 Date: Sun, 24 Oct 2021 16:57:35 GMT Content-Type: text/html Content-Length: 134 Connection: keep-alive Location: https://plegridyhcp.com:443/ HTTP/2 301 date: Sun, 24 Oct 2021 16:57:35 GMT content-type: text/html; charset=iso-8859-1 location: https://www.plegridyhcp.com/ set-cookie: AWSALB=L0pHmCzO78LVvMCn9PgbypPDAQ8ZEWU7hR8T51lWw4HPtzyNBaCG2/ahvlH0g0dnFzczC1rWa+WF9Zp3m7U5/E83WYMJvEDYlus1x6Nssuy6fQW5FcxKwtkV68Ie; Expires=Sun, 31 Oct 2021 16:57:35 GMT; Path=/ set-cookie: AWSALBCORS=L0pHmCzO78LVvMCn9PgbypPDAQ8ZEWU7hR8T51lWw4HPtzyNBaCG2/ahvlH0g0dnFzczC1rWa+WF9Zp3m7U5/E83WYMJvEDYlus1x6Nssuy6fQW5FcxKwtkV68Ie; Expires=Sun, 31 Oct 2021 16:57:35 GMT; Path=/; SameSite=None; Secure server: Apache x-frame-options: SAMEORIGIN HTTP/2 200 content-type: text/html; charset=UTF-8 date: Sun, 24 Oct 2021 16:57:36 GMT set-cookie: AWSALB=+pSjA0FOyJzRQjlNA1C6CpI5le1rNMQYy5afU+tT+NYFP5Hs9uXBIFxlICPzbdx19qH/FQEv2a/t1lg603rJf7SEFDd5lPp2g60NtAo/af9ez8JdM0+FW5X7iQFf; Expires=Sun, 31 Oct 2021 16:57:36 GMT; Path=/ set-cookie: AWSALBCORS=+pSjA0FOyJzRQjlNA1C6CpI5le1rNMQYy5afU+tT+NYFP5Hs9uXBIFxlICPzbdx19qH/FQEv2a/t1lg603rJf7SEFDd5lPp2g60NtAo/af9ez8JdM0+FW5X7iQFf; Expires=Sun, 31 Oct 2021 16:57:36 GMT; Path=/; SameSite=None; Secure server: Apache x-frame-options: SAMEORIGIN accept-ranges: bytes access-control-allow-origin: SAMEORIGIN vary: Accept-Encoding x-cache: Miss from cloudfront via: 1.1 321074a1c5e18849f73b879523fda326.cloudfront.net (CloudFront) x-amz-cf-pop: ORD52-C2 x-amz-cf-id: C_iVnWzI5_jfjaNqOdl3p054VTFxGG95eTyGA6Pc9XcjiEhn5sh3cQ== |
plegridyhcp.com Whois Information
Domain Name: PLEGRIDYHCP.COM Registry Domain ID: 1842942384_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-01-11T06:11:29Z Creation Date: 2014-01-15T13:15:42Z Registry Expiry Date: 2022-01-15T13:15:42Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1198.AWSDNS-21.ORG Name Server: NS-2023.AWSDNS-60.CO.UK Name Server: NS-264.AWSDNS-33.COM Name Server: NS-615.AWSDNS-12.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T23:28:05Z <<< |